<DOC>
	<DOCNO>NCT00230464</DOCNO>
	<brief_summary>Incretin hormone ( GIP GLP-1 ) stimulate insulin release glucose dependant manner , hence necessary maintenance normal glucose tolerance . Both GIP GLP-1 degrade inactivated DPP-4 . LAF 237 inhibitor DPP-4 show increase meal-stimulated level intact GLP-1 animal patient T2DM.. The purpose current study explore acute effect LAF237 rate appearance disappearance glucose type 2 diabetic . Secondary objective include effect FPG , insulin secretion rate , glucagon FFA level , rate glucose entry GI tract .</brief_summary>
	<brief_title>Acute Metabolic Effects LAF 237 Type 2 Diabetics</brief_title>
	<detailed_description>Study Design Double blind , placebo-controlled , randomize , two –period crossover study . Sixteen ( 16 ) sex diabetic patient enrol randomized receive one two treatment sequence ( LAF-placebo placebo-LAF ) . At screening , patient begin weight maintain diet contain 50 % carbohydrate , 30 % protein 20 % fat . Within 7 day screen patient schedule treatment 1 . Patients begin 10-hour overnight fast Day -1 ~21h00 . Patients admit GCRC next day . Fasting plasma glucose sample drawn follow patient serve standard breakfast contain 1/5 caloric allotment ( 50 % carbohydrate , 30 % protein 20 % fat ) . At noon patient feed standard lunch contain 2/5 caloric allotment ( 50 % carbohydrate , 30 % protein 20 % fat ) . At 14h30 ( -210 ) infusion 3-3H glucose start continue 08h00 next day ( 20 µCi x FPG/100 continuous , 0.20/min ) . At 17h30 ( -30 ) patient ingest 100 mg LAF237 placebo 200 ml water . At 18h00 ( time zero ) patient serve dinner ( 2/5 caloric allotment ) . The carbohydrate ( glucose ) meal label 75 µCi [ 1-14C ] -glucose . At -60 , -50 , -40 , -35 , -30 , -20 , -10 , -5 , 0 minute dinner plasma sample determination glucose , insulin , C-peptide , glucagon , GLP-1 , GIP , FFA , lactate , amino acid concentration 3-3H glucose radioactivity drawn . Following dinner , blood sample draw every 15 minute 3.5 hour ( 18h00-21h30 ) every 30 minute next 10.5 hour ( 22h00-08h00 Day 2 ) . Post dinner sample analyze parameter well 14C glucose radioactivity . At 08h00 Day 2 , catheter remove patient feed breakfast release site . In addition blood sample , urine dinner time 08h00 Day 2 collect .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vildagliptin</mesh_term>
	<criteria>1 . Age 1875 year type 2 diabetes , male female ( nonpregnant ) 2 . Time diagnosis : within 6 month prior screen , 1 month prior screen detectable antiGAD Abs 3 . Normal physical exam , EKG , blood test , urinalysis 4 . HbA1c=711 % screen 5 . FPG=160280 mg/dl screen 6 . Diabetes control diet exercise alone stable dosage metformin sulfonylurea 7 . BMI=2245 kg/m2 stable ( +/ 2.5 kg ) weight last 6 month 8 . Compliant study requirement &amp; write consent . 1 . Pregnant lactate female 2 . History : type 1 DM , pancreatic injury , secondary diabetes ( Cushing , acromegaly ) , acute metabolic complication ( ketoacidosis hyperosmolar state ) within past 6 month , torsades des pointes , ventricular tachycardia ventricular fibrillation 3 . Any follow within past 6 month : MI , CABG , unstable angina 4 . ECG abnormality : second degree AV block ( Mobitz 1 2 ) , third degree AV block , prolong QTc ( &gt; 450 m ) 5 . Use following medication : class Ia , Ib , Ic III antiarrhythmic , insulin , thiazolidinediones , corticosteroid 6 . Investigational drug treatment within 4 week prior screen unless local health authority guideline mandate longer period 7 . Fasting triglyceride &gt; 700 mg/dl screen 8 . Diabetic complication 9 . Renal disease ( creatinine &gt; 1.5 mg/dlmales &gt; 1.4 mg/dlfemale ) , renal failure , hepatic dysfunction , thyrotoxicosis 10 . History gastrointestinal surgery ( partial bowel resection , partial gastric resection ) 11 . Donation one unit blood within 2 week transfusion within 8 week prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>diabetes</keyword>
	<keyword>rate appearance glucose</keyword>
	<keyword>insulin secretion</keyword>
	<keyword>glucagon</keyword>
</DOC>